Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010
Multiple Sclerosis as a Cause of Atrial Fibrillation and Electrocardiographic Changes
Arch Neurol 49:422-424, Schroth,W.S.,et al, 1992
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis
Neruol 90:852-854, Ferraro, D.,et al, 2018
Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018
Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002
Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Peripheral Nervous System Involvement in Multiple Sclerosis
Neurol 41:457-460, Zee,P.C.,et al, 1991
Neuromuscular Blockade
Lancet 335:382-384, , 1990
Pain Due to Lesions of Central Nervous System Removed by Sympathetic Block
BMJ 282:1026-1028, Loh,L.,et al, 1981
Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976
Multiple Sclerosis Associated with Defects in Neuromuscular Transmission
JNNP 35:385, Patten,B.M.,et al, 1972